Shanghai Sipeng Technology develops synthetic biology services and bio-based materials.
Founded in 2022 and based in Shanghai, China, Shanghai Sipeng Technology develops synthetic biology services and bio-based products. Incubated by Shanghai Jiao Tong University's Laboratory of Microbial Metabolism, it operates a branch in Suzhou and has developed a negative-carbon manufacturing platform. Its product pipeline includes materials, polymer monomers and high-value compounds for uses such as polyester, cosmetics, agriculture and medicine. In May 2025, it raised pre-Series A+ funding from Fortera Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in